Results 51 to 60 of about 10,075 (184)
Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm [PDF]
Iranian Journal of Immunology, 2022 Background: Vaccines are the most effective way to prevent Coronavirus 2 severe acute respiratory syndrome (SARS-CoV-2).Objectives: To compare the antibody response of healthy individuals vaccinated with either the AstraZeneca (ChAdOx1 nCoV-19) or the ...
Enayat Anvari +8 more
doaj +1 more source
, 2022 Raw data accompanying ' ChAdOx1 nCoV-19 (AZD1222) or ChAdOx1 nCoV-19-Beta (AZD2816) protect Syrian hamsters against the Beta, Delta, and Omicron variants of concern'
Neeltje van Doremalen (8816015)
core +1 more source
To what extent AstraZeneca ChAdOx1 nCoV-19 vaccine is safe and effective? Rapid systematic review
The Egyptian Journal of Bronchology, 2022 Until now, there are more than two hundred million confirmed cases of COVID-19 including more than seven million deaths. Clinical trials of all three vaccines authorized for use in the UK (Pfizer–BioNTech, Oxford–AstraZeneca, and Moderna) have reported ...
Aliae A. R. Mohamed Hussein +4 more
doaj +1 more source
Mechanical prosthetic valve thrombosis after ChAdOx1-nCoV-19 vaccination: A case report
IHJ Cardiovascular Case Reports, 2022 The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in India. Vaccine induced thrombotic thrombocytopenia (VITT) is a rare but serious adverse effect of the ChAdOx1 nCoV-19 vaccine, causing widespread ...
Akash Jain +2 more
doaj +1 more source
Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination [PDF]
Case Reports in Critical Care, 2022 Vaccine-induced thrombotic thrombocytopenia is an uncommon complication of COVID-19 vaccines using adenovirus mRNA carriers and has been associated with thrombosis of the cerebral venous sinuses and portal system. We report a case of a 69-year-old woman admitted to the intensive care unit due to stroke caused by thrombosis of the right carotid artery 9
Giorgio Berlot +5 more
openaire +4 more sources
Frontiers in Immunology, 2021 Response to vaccines generally varies according to individual factors of the vaccinated subjects such as demographics and immune status. While there are various reports of factors associated with immunogenicity of mRNA COVID-19 vaccines, little is known ...
Sang Won Lee +13 more
doaj +1 more source
Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine
BMJ Case Reports, 2022 Cryoglobulinaemic vasculitis is an immune-complex-mediated, systemic inflammatory syndrome usually involving small-to-medium vessels due to precipitation of cryoglobulins at <37°C. It can involve any organ but most commonly affects the skin. Associated conditions include infections (hepatitis C and HIV), haematological disorders (chronic lymphocytic
Sadaf Ahmer +2 more
openaire +2 more sources
Cerebral Venous Thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review [PDF]
, 2023 OBJECTIVE: To perform a systematic review of case reports or case series regarding thrombosis with thrombocytopenia syndrome (TTS) and cerebral venous thrombosis (CVT) related to ChAdOx1 nCoV-19 vaccination to address the clinical features, laboratory ...
Dong Keon Yon (3843409) +13 more
core +3 more sources
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination [PDF]
Nature Medicine, 2021 Abstract Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in Germany, although data on immunogenicity and reactogenicity are not available.
Schmidt, Tina +14 more
openaire +3 more sources
Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports
Journal of Medical Case Reports, 2022 Highlights/Take-away message 1. The Chimpanzee Adenovirus-vectored Vaccine (ChAdOx1 nCoV-19 vaccine) has been widely used in Himalayan Country, Nepal and India. 2.
Mukesh Kumar Sah +6 more
doaj +1 more source